It has long been assumed that psychostimulants help those with ADHD by acting on the brain’s attention circuitry. However, new research finds that this is not the case.
GlobalData on MSN
FDA accepts Otsuka’s centanafadine application for ADHD treatment
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
Arynta is a medicine used to treat attention deficit hyperactivity disorder (ADHD). ADHD is a common condition in children, and it also affects adults. ADHD affects how you pay attention, focus, and ...
FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.
The use of prescription medications for Attention-Deficit Hyperactivity Disorder has tripled in the last decade - with women ...
Early drug treatment for ADHD in Sweden was tied to reduced risk of suicidal behavior, substance misuse, transport accidents, and crime. Benefits extended to recurrent events, possibly due to improved ...
Women are driving soaring use of ADHD medication, experts say. Researchers from the University of Oxford highlighted a 20-fold rise in use of drugs to manage the condition among w ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results